SEBI has issued a consultation paper dated November 6, 2026, Consultation Paper, in which SEBI has proposed the introduction of a certification requirement for the Principal Officer of all intermediaries registered with SEBI under Section 12 of the SEBI Act, 1992. The authors compare the requirements with the IFSCA's certification requirement.
The article discusses the broader question as to whether payments made under a tariff regime subsequently held unlawful continue to be treated as ‘United States import duties’ for purposes of calculating dumping margins.
On 5 November 2026, SEBI issued a circular prescribing the operational details of a new regulatory framework for Accredited Investors. This circular was preceded by a consultation paper dated 13 August 2026, and approval by SEBI board of the proposals in such consultation paper. In this article, we have reviewed the key features of the new regulatory framework for Accredited Investors rolled out by SEBI.
The article discusses recent CBIC Instruction No. 17/2026-Cus., which permits Customs adjudication under Section 28AAA in certain circumstances without prior DGFT invalidation of licences or scrips.
The article examines the Rajasthan High Court’s recent decision on interest demands for unused goods imported under MOOWR and cleared ‘as such’. It explains that Section 61(2) of the Customs Act, 1962 applies only to goods under Section 61(1)(c), not qualifying manufacturing goods under clauses (a) and (b).
The Department for Promotion of Industry and Internal Trade, Government of India (“DPIIT”) had vide press note 3 of 2020 dated April 17, 2020 (“Press Note 3”) amended the extant foreign direct investment (FDI) policy dated August 28, 2017. As per Press Note 3, the amendment was introduced with an aim to curb opportunistic takeovers of Indian companies by persons or entities (directly or indirectly) of any country which shares a land border with India (“Bordering Country”) during difficult times
The lockdowns due to COVID-19 in various countries have shrunk global trade with countries choosing to protect their people first before opening any further borders. The Government has also been tweaking the Import and Export Policy for many goods keeping in view the requirement of these goods in India. The Government has also issued an Ordinance, circulars, press releases, etc., on various relief measures for the benefit of the trade and industry.
Due to the current lockdown, the Government has introduced certain relief measures for the industries by extending the timelines for statutory and regulatory compliances under various laws. In this regard, the Finance Ministry has issued multiple notifications on 03-04-2020. A snapshot of the notifications relevant for present discussion is as under:
In the International trade scenario, World Trade Organization (“WTO”) provides an operating framework which facilitates free trade between its member-countries. The Dispute Settlement Understanding (“DSU”) is a legal text containing the rules for dispute settlement in the WTO. The Dispute Settlement Body (“DSB”) comprising of representatives of all WTO Members, administers the DSU and is responsible for overseeing the entire dispute settlement process.
Business environment has undergone a drastic change i.e. from the traditional ‘physical system’ to the modern ‘digital system’. With user/ consumer facing countries devising measures to tax digital businesses, the International tax landscape is certainly undergoing a renovation.
The extant COVID-19 pandemic has been plaguing individuals and industries alike. The Government of India has, with a view to curb opportunistic takeovers/acquisitions of Indian companies due to the COVID-19 pandemic, reviewed and revised the extant foreign direct investment (“FDI”) policy dated August 28, 2017 (“FDI Policy”), issued by the Department for Promotions of Industry and Internal Trade (“DPIIT”) vide press note 3 of 2020 dated April 17, 2020
In an effort to streamline the functioning of tribunals in India, the Finance Act, 2017 brought appeals filed against the orders of the Competition Commission of India (CCI)under the Competition Act, 2002 (CompetitionAct) within the purview of the National Company Law Appellate Tribunal (NCLAT).
Indian Council of Medical Research (hereinafter referred as the ‘ICMR’) has recently come up with letter of intent inviting hospitals and institutions to participate in randomized controlled study of Therapeutic Plasma Exchange in critically infected covid-19 patients. This is also being referred to as the ‘Convalescent Plasma Therapy’.
Businesses across the world have been impacted by the global pandemic, COVID – 19 and State measures have brought many economies to a standstill. It is inevitable that the next few months are going to present new challenges to businesses.While certain industries such as airlines, entertainment, hotels etc. will struggle to get back on their feet, essential commodities, pharmaceuticals and healthcare providers will be strained with unprecedented demand.
The global sports market is an estimated $600 billion industry1, comprising of infrastructure, events, training, manufacturing and retail. The scale and revenue-generating opportunities are most visible during marquee international sporting events.
Coronavirus, which originated from the Wuhan district of China, has been declared as a health emergency of international concern by the World Health Organization on January 30, 2020. The outbreak of the novel Coronavirus Disease (“COVID-19”) has transcended geographical barriers and already sickened approximately 15,00,00 people, with more than 85,000 deaths across the globe.
The rules of the Bar Council of India prohibit law firms from advertising and soliciting work through communication in the public domain. This website is meant solely for the purpose of information and not for the purpose of advertising. Lakshmikumaran & Sridharan does not intend to solicit clients through this website. We do not take responsibility for decisions taken by the reader based solely on the information provided in the website. By clicking on 'ACCEPT', the visitor acknowledges that the information provided in the website (a) does not amount to advertising or solicitation and (b) is meant only for his/her understanding about our activities and who we are.
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy.